Equity Research

Kenji Yasui and Jaime Manzone will retain their current roles in addition to their new responsibilities.

After the rapid strides it has made as a destination for biotech listings in less than three years, Hong Kong now faces bigger challenges in overtaking New York.

Various interpretations of ESG invite criticism that responsible objectives are not being met – but these shortfalls may help its cause.

A reputable sponsor and an attractive yield offering will likely draw local interest for Ayala Land’s office REIT, even as the coronavirus redefines traditional office space demand

Ironically, Yum China may be able to utilise the current health pandemic for their listing advantage as they consider following ADRs JD.com and NetEase to Hong Kong.

Alibaba came back to Asia in November and dominated the equity landscape. But people are now starting to ask what markets next year are going to look like.

Dealogic data shows that Budweiser's deal boosted the IPO value of the food and beverage sector in Asia sevenfold in September.

Sterling & Wilson Solar's flotation topped Asia's IPO deal list by value last month, according to Dealogic. But market reaction to the renewable energy company highlights concerns for its future growth.